The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Note 10 - Other Intangible Assets, Net (Details Textual) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	May 31, 2016	May 31, 2016	May 31, 2015	May 31, 2014
In Process Research and Development [Member] \| Transfusion [Member]
Impairment of Intangible Assets (Excluding Goodwill)		$ 2.5
In Process Research and Development [Member] \| Transplant & Molecular [Member]
Impairment of Intangible Assets (Excluding Goodwill)		0.5
In Process Research and Development [Member]
Impairment of Intangible Assets (Excluding Goodwill)	$ 3.0
Amortization of Intangible Assets		$ 54.9	$ 54.5	$ 53.0